HARBIN, China, June 3 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (Amex: CSY) ("China Sky One Medical", "CSY"), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, today announced today that five of its products have received production permit approvals from the SFDA.
Over a year ago, China Sky One Medical began to develop products with large potential global market demand in an effort to expand the Company's export business. The Company established a R&D team dedicated to the development of these products in February 2006. China Sky One Medical has successfully completed pharmacokinetics studies, clinical studies and the manufacturing process for the following patches:
Anti-smoking patch -- breaks down nicotine and other harmful chemical compounds related to cigarette smoking and reduces dependence on cigarettes;
Scar patch -- speeds up the healing of the wounds due to trauma and surgeries and reduces the likelihood of developing permanent scars;
Migraine patch -- provides quick pain relief for migraine sufferers while alleviating dizziness and nausea;
Eye patch -- relaxes the muscles in the retina, which helps to reduce the likelihood of developing myopia;
Coronary heart disease patch -- increases blood circulation in coronary arteries, which reduces the incidences of coronary heart disease and myocardial infarction.
These patches were developed after extensive research into the market potential by China Sky One Medical's business development team. The Company has received purchase orders for some products, such as the anti-smoking patch, prior to receipt of the production permit.
"Since most of these products util
|SOURCE China Sky One Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved